Skip to content

What is mithra numbing cream?

6 min read

In 2024, the U.S. Food and Drug Administration (FDA) issued a warning against certain high-concentration topical anesthetics, including products associated with Mithra+, for exceeding safe levels of active ingredients. This raises serious questions for consumers: what is mithra numbing cream?

Quick Summary

Mithra numbing cream is a potent topical anesthetic containing high concentrations of lidocaine and prilocaine, widely used for pain relief during cosmetic procedures. Its use carries significant safety risks due to unapproved ingredient levels, as noted by FDA warnings.

Key Points

  • High-Concentration Anesthetic: Mithra numbing cream contains potent, unapproved concentrations of active ingredients like lidocaine and prilocaine, well above levels permitted for standard OTC use.

  • FDA Safety Warnings: The FDA has issued warnings against distributors of Mithra+ products, citing serious health risks from the high concentration of active ingredients.

  • Significant Risks: Improper or excessive use can lead to life-threatening side effects, including systemic toxicity and methemoglobinemia.

  • Used for Cosmetic Procedures: It is commonly used to reduce pain during tattoos, piercings, permanent makeup, and laser treatments.

  • Safer Alternatives Available: Medically-supervised compounded creams and FDA-approved OTC products offer safer alternatives for topical pain relief.

  • Professional Guidance is Essential: Consulting a healthcare provider or a professional for guidance is crucial before using any potent topical anesthetic to ensure safety.

  • Requires Patch Testing: It is recommended to perform a patch test before every use to check for skin sensitivity or allergic reactions.

In This Article

What is Mithra Numbing Cream?

Mithra numbing cream is a topical anesthetic formulated to provide temporary pain relief for various cosmetic and aesthetic procedures. It is frequently marketed and sold to individuals preparing for procedures such as tattoos, piercings, and permanent makeup. Unlike standard over-the-counter (OTC) numbing creams, products like Mithra often contain a high concentration of active anesthetic ingredients, typically including lidocaine and prilocaine, along with epinephrine. This potent formula is what gives it a reputation for strong and fast-acting numbing effects, but it is also the source of serious regulatory and safety concerns.

How the Active Ingredients Work

The strong numbing effect of Mithra cream comes from its combination of active pharmaceutical ingredients:

  • Lidocaine: A local anesthetic that works by reversibly blocking nerve signals in a specific area of the body. By interfering with the flow of sodium ions, it prevents nerve cells from sending pain messages to the brain, resulting in a numbing sensation.
  • Prilocaine: Another local anesthetic, often used in combination with lidocaine to create a stronger and more effective topical numbing effect. The combination of these two agents in a cream is a well-established practice in medical settings, but the concentrations used in some products like Mithra are not approved for OTC sale by regulatory bodies like the FDA.
  • Epinephrine: A vasoconstrictor, meaning it narrows local blood vessels. Including epinephrine in the formula helps to localize the anesthetic effect by reducing blood flow to the treated area. This can prolong the numbing effect and reduce swelling or bleeding during the procedure.

When applied to the skin, these ingredients are absorbed and act on the local nerve endings to produce a profound numbing effect that can last for several hours, depending on the application and the individual's skin.

Common Uses of Mithra Cream

Mithra cream is marketed for a variety of skin-invasive procedures where pain management is desired. Users and professionals in the aesthetics industry often apply it for:

  • Tattoos: The most common application, helping to reduce the pain associated with the tattooing process, especially for larger or more sensitive areas.
  • Permanent Makeup: Used for procedures on the eyebrows, lips, and eyeliner to minimize discomfort.
  • Microneedling: Applied before the treatment to prepare the skin for the small needles.
  • Body Piercings: Can be used to numb the area before a piercing is performed.
  • Laser Treatments: Aids in managing the pain from laser hair removal, resurfacing, and IPL (Intense Pulsed Light) treatments.
  • Waxing: Some users report using it to reduce pain during body and bikini waxing.

Application Considerations

For optimal numbing effect, careful application is crucial. While manufacturers and suppliers provide specific instructions, users should be mindful of the following general steps, noting that the appropriate technique can impact efficacy and absorption:

  1. Preparation: Thoroughly wash and clean the area to be treated. Ensuring the skin is clean and dry is often recommended.
  2. Application: Apply a layer of the cream to the skin. Some instructions suggest applying a thick layer without rubbing it in completely at this stage.
  3. Occlusion: Covering the applied cream with plastic wrap or an occlusive dressing for a specific period is often advised. This method is believed to enhance absorption and prevent the cream from drying out.
  4. Procedure: The cream is typically removed just before the procedure begins. The treated area may remain numb for a period following application.

Safety Concerns and FDA Warnings

The high potency of Mithra numbing cream is a double-edged sword. While it offers strong pain relief, it also presents significant health risks, especially due to its non-FDA-compliant formulation. In March 2024, the FDA issued a warning letter to the distributor of Mithra+ numbing creams, highlighting serious safety issues.

The primary danger lies in the high concentrations of lidocaine, prilocaine, and epinephrine, which, when absorbed systemically (into the bloodstream), can cause serious, life-threatening side effects, including:

  • Methemoglobinemia: A rare but serious blood condition where red blood cells carry less oxygen. Symptoms include pale, gray, or blue-colored skin, lightheadedness, and shortness of breath.
  • Systemic Toxicity: Over-absorption of anesthetics can lead to symptoms like confusion, dizziness, seizures, and slowed breathing.
  • Cardiovascular Issues: High absorption can cause irregular heartbeats and, in extreme cases, heart failure.
  • Allergic Reactions: Severe burning, blistering, or swelling at the application site can indicate an allergic response.

These risks are heightened when applying the cream over large areas, on broken or irritated skin, or when using excessive amounts. The FDA explicitly states that these products are not generally recognized as safe and effective for OTC use due to their unauthorized formulation. For this reason, it is crucial to consult with a healthcare provider or a professional for guidance on safe and appropriate topical pain management options.

Mithra Cream vs. FDA-Compliant Numbing Creams

To better understand the risks associated with high-concentration products like Mithra, it is useful to compare them with FDA-compliant alternatives. While OTC creams often have lower concentrations, compounded creams can offer higher concentrations under medical supervision.

Feature Mithra Numbing Cream FDA-Compliant OTC Numbing Cream (e.g., EMLA) Compounded Numbing Cream
Active Ingredients High concentration of lidocaine (10%), prilocaine (5%), epinephrine (1%). Approved concentrations, e.g., lidocaine 2.5% and prilocaine 2.5%. Custom concentrations of anesthetics like lidocaine, prilocaine, tetracaine, and benzocaine.
Regulation Not FDA-approved for OTC sale; subject to FDA warning letters. Adheres to FDA's OTC monograph regulations. Made by a licensed compounding pharmacy under a specific prescription.
Availability Available through online vendors and some tattoo supply stores, often without a prescription. Readily available at drugstores over-the-counter. Available only with a prescription from a healthcare provider.
Safety Profile Significant safety risks due to high, unapproved concentrations; risk of systemic toxicity and methemoglobinemia. Lower risk of systemic side effects due to regulated concentrations; generally considered safe when used as directed. Formulated for individual patient needs by a pharmacist under medical supervision, mitigating risk.
Efficacy Often reports very strong and long-lasting numbing (3-5 hours), but with elevated risk. Provides mild to moderate numbing, effective for minor procedures. Can provide powerful, long-lasting anesthesia tailored to the specific procedure.

Alternatives to High-Concentration Numbing Creams

Given the serious risks associated with high-concentration topical anesthetics like Mithra, several safer alternatives are available for those seeking pain relief during procedures. These alternatives vary in their mechanism and potency, but prioritize safety and regulatory compliance.

  • OTC Numbing Creams: Standard topical anesthetics available at pharmacies, such as EMLA cream (a blend of lidocaine and prilocaine in lower, FDA-approved concentrations), are a safer option for minor procedures.
  • Prescription Compounded Creams: For more significant pain management needs, a healthcare provider can prescribe a custom-compounded cream with higher concentrations of anesthetic agents. These are prepared by a licensed pharmacy under medical supervision, which significantly reduces the risk of adverse effects.
  • Alternative Methods: For minor discomfort, some people consider natural remedies like aloe vera for cooling or clove oil for its numbing properties. However, these should be approached with caution as efficacy and safety are less regulated.

Conclusion

While Mithra numbing cream is marketed as a powerful solution for reducing pain during tattoos and other cosmetic procedures, its high concentration of active ingredients and lack of FDA approval pose significant health risks. Potential side effects, including rare but life-threatening conditions like methemoglobinemia, make it a hazardous choice for many consumers. Safer, more regulated alternatives exist, from standard OTC products to medically-supervised compounded creams. Ultimately, prioritizing safety and consulting with a healthcare professional before using any potent topical anesthetic is crucial for protecting one's health while pursuing cosmetic enhancements. For further information on the risks of unapproved topical anesthetics, consumers can refer to the FDA's warnings.

Food and Drug Administration (.gov): TKTX Company - 673879 - 03/25/2024

Frequently Asked Questions

No, Mithra numbing cream and similar products with high concentrations of active ingredients are not considered safe by regulatory bodies like the FDA. The FDA has issued warnings against these products due to the risk of serious side effects like methemoglobinemia and systemic toxicity.

The active ingredients typically found in Mithra+ products include a high concentration of lidocaine (10%), prilocaine (5%), and epinephrine (1%). This potent combination is what provides the strong numbing effect but also elevates the safety risks.

According to vendors, the numbing effect can last between 3 and 5 hours after proper application with an occlusive dressing. The duration can vary based on the individual's skin type and the specific area of application.

Beyond typical skin irritation and redness, serious side effects can include systemic toxicity symptoms like dizziness, seizures, and irregular heartbeat. Life-threatening conditions like methemoglobinemia, a blood disorder, are also a risk.

Safer alternatives include FDA-approved over-the-counter numbing creams, which contain lower, regulated concentrations of anesthetics like lidocaine and prilocaine. For more potent, yet medically-supervised options, a healthcare provider can prescribe a custom-compounded cream.

The legality of selling Mithra-like products is questionable. The FDA has issued warning letters regarding their sale in the US, indicating they are not authorized for OTC use and fail to meet safety and effectiveness standards for external analgesics.

While it is marketed for piercings, its use is strongly discouraged due to significant safety risks. The potential for systemic toxicity and methemoglobinemia outweighs any temporary pain relief, especially in sensitive areas.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.